File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Treatment of heart failure in long-term dialysis patients: A reappraisal

TitleTreatment of heart failure in long-term dialysis patients: A reappraisal
Authors
Keywordsdialysis
Issue Date2011
Citation
American Journal of Kidney Diseases, 2011, v. 57, n. 5, p. 760-772 How to Cite?
AbstractHeart failure is one of the most frequent cardiac complications in patients with end-stage renal disease receiving long-term hemodialysis or peritoneal dialysis and is associated strongly with a poor prognosis. Despite the significant morbidity and mortality associated with heart failure, there are very limited therapeutic options proved to prevent and treat heart failure in dialysis patients. This limitation largely reflects the paucity of adequately powered prospective randomized clinical trials that have examined the efficacy of different therapeutic options in long-term dialysis patients with heart failure. In this article, the second in a series discussing the management of heart failure in dialysis patients, current therapeutic options for heart failure in the maintenance dialysis population are reviewed and potential novel therapeutic options are discussed. © 2011 National Kidney Foundation, Inc.
Persistent Identifierhttp://hdl.handle.net/10722/228463
ISSN
2015 Impact Factor: 6.269
2015 SCImago Journal Rankings: 2.313

 

DC FieldValueLanguage
dc.contributor.authorWang, Angela Yee Moon-
dc.contributor.authorSanderson, John E.-
dc.date.accessioned2016-08-13T08:02:28Z-
dc.date.available2016-08-13T08:02:28Z-
dc.date.issued2011-
dc.identifier.citationAmerican Journal of Kidney Diseases, 2011, v. 57, n. 5, p. 760-772-
dc.identifier.issn0272-6386-
dc.identifier.urihttp://hdl.handle.net/10722/228463-
dc.description.abstractHeart failure is one of the most frequent cardiac complications in patients with end-stage renal disease receiving long-term hemodialysis or peritoneal dialysis and is associated strongly with a poor prognosis. Despite the significant morbidity and mortality associated with heart failure, there are very limited therapeutic options proved to prevent and treat heart failure in dialysis patients. This limitation largely reflects the paucity of adequately powered prospective randomized clinical trials that have examined the efficacy of different therapeutic options in long-term dialysis patients with heart failure. In this article, the second in a series discussing the management of heart failure in dialysis patients, current therapeutic options for heart failure in the maintenance dialysis population are reviewed and potential novel therapeutic options are discussed. © 2011 National Kidney Foundation, Inc.-
dc.languageeng-
dc.relation.ispartofAmerican Journal of Kidney Diseases-
dc.subjectdialysis-
dc.titleTreatment of heart failure in long-term dialysis patients: A reappraisal-
dc.typeArticle-
dc.description.natureLink_to_subscribed_fulltext-
dc.identifier.doi10.1053/j.ajkd.2011.01.014-
dc.identifier.pmid21349619-
dc.identifier.scopuseid_2-s2.0-79954601364-
dc.identifier.volume57-
dc.identifier.issue5-
dc.identifier.spage760-
dc.identifier.epage772-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats